NYSE · CRL

Charles River Laboratories International, Inc.

Healthcare · Medical - Diagnostics & Research

$272.88

Up+$1.87 (+0.69%)

Updated Sep 16, 2026, 2:55 PM

SID Score

6.2/10

Composite research score

Smart Money

62/100

Neutral

Price performance

CRL price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

Market data is busy. Please try again shortly.

The latest Smart Investors Daily articles mentioning CRL.

The latest Smart Investors Daily articles mentioning CRL.

Stock researchCompany · Earnings

Company

Market Activity

Research & News

CRL research

Reported results, surprises, and transcripts.

Report date	Quarter	Year	EPS actual	EPS estimate	EPS surprise	Revenue
Aug 5, 2026	Q2	2,026	$3.02	$2.73	+0.11%	1B
May 7, 2026	Q1	2,026	$2.06	$1.95	+0.06%	995.83M
May 6, 2026	Q1	2,026	—	$1.94	—	—
Feb 18, 2026	Q4	2,025	$2.39	$2.34	+0.02%	994.23M
Feb 17, 2026	Q4	2,025	—	$2.3668	—	—
Sep 30, 2025	Q3	2,025	$2.43	$2.3619	+2.88%	—
Jun 30, 2025	Q2	2,025	$3.12	$2.5226	+23.68%	—
Mar 31, 2025	Q1	2,025	$2.34	$2.0999	+11.43%	—
Dec 31, 2024	Q4	2,024	$2.66	$2.557	+4.03%	—
Sep 30, 2024	Q3	2,024	$2.59	$2.4503	+5.70%	—
Jun 30, 2024	Q2	2,024	$2.80	$2.418	+15.80%	—
Mar 31, 2024	Q1	2,024	$2.27	$2.0896	+8.63%	—
Dec 31, 2023	Q4	2,023	$2.46	$2.4264	+1.38%	—
Sep 30, 2023	Q3	2,023	$2.72	$2.392	+13.71%	—
Jun 30, 2023	Q2	2,023	$2.69	$2.6647	+0.95%	—
Mar 31, 2023	Q1	2,023	$2.78	$2.6142	+6.34%	—
Dec 31, 2022	Q4	2,022	$2.98	$2.773	+7.46%	—
Sep 30, 2022	Q3	2,022	$2.63	$2.52	+4.37%	—
Jun 30, 2022	Q2	2,022	$2.77	$2.7618	+0.30%	—
Mar 31, 2022	Q1	2,022	$2.75	$2.7429	+0.26%	—